An update on the pathogenesis of the upper airways in aspirin-exacerbated respiratory disease

Current Opinion in Allergy and Clinical Immunology

Volumn 14, Issue 1, 2014, Pages 1-6

  Choi, Jeong Hee ^a   Kim, Mi Ae ^b   Park, Hae Sim ^b  

^a Hallym University   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

aspirin hypersensitivity; asthma; chronic rhinosinusitis; nasal polyp

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 2; EOTAXIN; IMMUNOGLOBULIN E; INTERLEUKIN 5; LIPOXYGENASE; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E2; STAPHYLOCOCCUS ENTEROTOXIN; TRANSCRIPTION FACTOR RUNX2; BACTERIUM ANTIBODY; CYTOKINE;

ARACHIDONIC ACID METABOLISM; ASPIRIN EXACERBATED RESPIRATORY DISEASE; BLOOD VESSEL PERMEABILITY; BRONCHOCONSTRICTION; CELL INTERACTION; CHRONIC RHINOSINUSITIS; DOWN REGULATION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; INFLAMMATORY CELL; INFLAMMATORY DISEASE; NOSE POLYP; NOSE PROVOCATION TEST; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; REVIEW; UPREGULATION; ANIMAL; CHRONIC DISEASE; EOSINOPHIL; IMMUNOLOGY; METABOLISM; RESPIRATORY TRACT INFECTION; RHINITIS; SINUSITIS; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTIBODIES, BACTERIAL; ARACHIDONIC ACID; ASTHMA, ASPIRIN-INDUCED; CHRONIC DISEASE; CYTOKINES; EOSINOPHILS; HUMANS; IMMUNOGLOBULIN E; NASAL POLYPS; RESPIRATORY TRACT INFECTIONS; RHINITIS; SINUSITIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

EID: 84892371942     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0000000000000021     Document Type: Review

References (53)

1. Lee RU, Stevenson DD. Aspirin-exacerbated respiratory disease: Evaluation and management. Allergy Asthma Immunol Res 2011; 3:3-10
2. Chang HS, Park JS, Jang AS, et al. Diagnostic value of clinical parameters in the prediction of aspirin-exacerbated respiratory disease. Allergy Asthma Immunol Res 2011; 3:256-264
3. Samter M, Beers RF Jr. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med 1968; 68:975-983
4. Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 2000; 16:432-436
5. Mullol J, Picado C. Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease. Immunol Allergy Clin North Am 2013; 33:163-176
6. Laidlaw TM, Boyce JA. Pathogenesis of aspirin-exacerbated respiratory disease and reactions. Immunol Allergy Clin North Am 2013; 33:195-210
7. Samuelsson B, Dahlén SE, Lindgren JA, et al. Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects. Science 1987; 237:1171-1176
8. Higashi N, Taniguchi M, Mita H, et al. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol 2004; 113:277-283
9. Higashi N, Taniguchi M, Mita H, et al. Aspirin-intolerant asthma (AIA) assessment using the urinary biomarkers, leukotriene E4 (LTE4) and prostaglandin D2 (PGD2) metabolites. Allergol Int 2012; 61:393-403
10. Micheletto C, Tognella S, Visconti M, et al. Changes in urinary LTE4 and nasal functions following nasal provocation test with ASA in ASA-tolerant andintolerant asthmatics. Respir Med 2006; 100:2144-2150
11. Picado C, Ramis I, Rosello J, et al. Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. Am Rev Respir Dis 1992; 145:65-69
12. Choi GS, Kim JH, Shin YS, et al. Eosinophil activation and novel mediators in the aspirin-induced nasal response in AERD. Clin Exp Allergy 2013; 43:730-740
13. Pé rez-Novo CA, Watelet JB, Claeys C, et al. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. J Allergy Clin Immunol 2005; 115:1189-1196
14. Laidlaw TM, Boyce JA. Cysteinyl leukotriene receptors, old and new: Implications for asthma. Clin Exp Allergy 2012; 42:1313-1320
15. Figueroa DJ, Borish L, Baramki D, et al. Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis. Clin Exp Allergy 2003; 33:1380-1388
16. Zhu J, Qiu YS, Figueroa DJ, et al. Localization and upregulation of cysteinyl leukotriene-1 receptor in asthmatic bronchial mucosa. Am J Respir Cell Mol Biol 2005; 33:531-540
17. Sousa AR, Parikh A, Scadding G, et al. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002; 347:1493-1499
18. Corrigan C, Mallett K, Ying S, et al. Expression of the cysteinyl leukotriene receptors cysLT(1) and cysLT(2) in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis. J Allergy Clin Immunol 2005; 115:316-322
19. Adamusiak AM, Stasikowska-Kanicka O, Lewandowska-Polak A, et al. Expression of arachidonate metabolism enzymes and receptors in nasal polyps of aspirin-hypersensitive asthmatics. Int Arch Allergy Immunol 2012; 157:354-362
20. Kim SH, Oh JM, Kim YS, et al. Cysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in males. Clin Exp Allergy 2006; 36:433-439
21. Yamaguchi H, Higashi N, Mita H, et al. Urinary concentrations of 15-epimer of lipoxin A4 are lower in patients with aspirin-intolerant compared with aspirintolerant asthma. Clin Exp Allergy 2011; 41:1711-1718
22. Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 1996; 271:33157-33160
23. Roca-Ferrer J,Garcia-Garcia FJ, Pereda J, et al. Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin-intolerant asthma. J Allergy Clin Immunol 2011; 128:66-72
24. Picado C, Fernandez-Morata JC, Juan M, et al. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1999; 160:291-296
25. Mullol J, Fernandez-Morata JC, Roca-Ferrer J, et al. Cyclooxygenase 1 and cyclooxygenase 2 expression is abnormally regulated in human nasal polyps. J Allergy Clin Immunol 2002; 109:824-830
26. Pujols L, Mullol J, Alobid I, et al. Dynamics of COX-2 in nasal mucosa and nasal polyps from aspirin-tolerant and aspirin-intolerant patients with asthma. J Allergy Clin Immunol 2004; 114:814-819
27. Sugimoto Y, Narumiya S. Prostaglandin E receptors. J Biol Chem 2007; 282:11613-11617
28. Bachert C, Gevaert P, Holtappels G, et al. Nasal polyposis: From cytokines to growth. Am J Rhinol 2000; 14:279-290
29. Han JK. Subclassification of chronic rhinosinusitis. Laryngoscope 2013; 123 (Suppl 2):S15-S27
30. Suh Y, Yoon S, Sampson A, et al. Specific immunoglobulin E for staphylococcal enterotoxins in nasal polyps from patients with aspirin-intolerant asthma. Clin Exp Allergy 2004; 34:1270-1275
31. Kowalski M, Grzegorczyk J, Pawliczak R, et al. Decreased apoptosis and distinct profile of infiltrating cells in the nasal polyps of patients with aspirin hypersensitivity. Allergy 2002; 57:493-500
32. Varga E, Jacobson M, Masuyama K, et al. Inflammatory cell populations and cytokine mRNA expression in the nasal mucosa in aspirin-sensitive rhinitis. Eur Respir J 1999; 14:610-615
33. SousaAR, Lams BE, Pfister R, et al. Expression of interleukin-5 and granulocytemacrophage colony-stimulating factorin aspirin-sensitive and nonaspirin-sensitive asthmatic airways. Am J Respir Crit Care Med 1997; 156:1384-1389
34. Pods R, Ross D, van Hulst S, et al. RANTES, eotaxin and eotaxin-2 expression and production in patients with aspirin triad. Allergy 2003; 58:1165-1170
35. Gevaert P, Van Bruaene N, Cattaert T, et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol 2011; 128:989-995
36. Palikhe NS, Kim SH, Cho BY, et al. Genetic variability in CRTH2 polymorphism increases eotaxin-2 levels in patients with aspirin exacerbated respiratory disease. Allergy 2010; 65:338-346
37. Bachert C, Zhang N. Chronic rhinosinusitis and asthma: Novel understanding of the role of IgE 'above atopy'. J Intern Med 2012; 272:133-143
38. Seiberling KA, Conley DB, Tripathi A, et al. Superantigens and chronic rhinosinusitis: Detection of staphylococcal exotoxins in nasal polyps. Laryngoscope 2005; 115:1580-1585
39. Pé rez-Novo CA, Kowalski ML, Kuna P, et al. Aspirin sensitivity and IgE antibodies to Staphylococcus aureus enterotoxins in nasal polyposis: Studies on the relationship. Int Arch Allergy Immunol 2004; 133:255-260
40. Conley DB, Tripathi A, Seiberling KA, et al. Superantigens and chronic rhinosinusitis: Skewing of T-cell receptor Vb-distributions in polyp-derived CD4and CD8T cells. Am J Rhinol 2006; 20:534-539
41. Patou J, Gevaert P, Van Zele T, et al. Staphylococcus aureusenterotoxin B, protein A, and lipoteichoic acid stimulations in nasal polyps. J Allergy Clin Immunol 2008; 121:110-115
42. Bachert C, Van Steen K, Zhang N, et al. Specific IgE against Staphylococcus aureus enterotoxins: An independent risk factor for asthma. J Allergy Clin Immunol 2012; 130:376-381
43. Yoo HS, Shin YS, Liu JN, et al. The role of staphylococcal superantigens in aspirin-exacerbated respiratory disease. Int Arch Allergy Appl Immunol 2013; 162:340-345
44. Gevaert P, Calus L, Van Zele T, et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol 2013; 131:110-116
45. Stankovic KM, Goldsztein H, Reh DD, et al. Gene Expression profiling of nasal polypsassociated with chronic sinusitis and aspirin-sensitive asthma. Laryngoscope 2008; 118:881-889
46. Jia G, Erickson RW, Choy DF, et al. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol 2012; 130:647-654
47. Liu Z, Kim J, Sypek JP, et al. Gene expression profiles in human nasal polyp tissues studied by means of DNA microarray. J Allergy Clin Immunol 2004; 114:783-790
48. Wang X, Dong Z, Zhu D-D, Guan B. Expression profile of immune-associated genes in nasal polyps. Ann Otol Rhinol Laryngol 2006; 115:450-456
49. Figueiredo CR, Santos RP, Silva ID, Weckx LL. Microarray cDNA to identify inflammatory genes in nasal polyposis. Am J Rhinol 2007; 21: 231-235
50. Park BL, Kim TH, Kim JH, et al. Genome-wide association study of aspirinexacerbated respiratory disease in a Korean population. Hum Genet 2013; 132:313-321
51. Choi JH, Lee KW, Oh HB, et al. HLA association in aspirin-intolerant asthma: DPB1-0301 as a strong marker in a Korean population. J Allergy Clin Immunol 2004; 113:562-564
52. Dekker J, Nizankowska E, Schmitz-Schumann M, et al. Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes. Clin Exp Allergy 1997; 27:574-577
53. Lee HY, Lee JW, Lee KW, et al. The HLA allele marker for differentiating ASA hypersensitivity phenotypes. Allergy 2009; 64:1385-1387